BlackRock’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,696
| Closed | -$20.8K | – | 5662 |
|
|
2025
Q1 | $20.8K | Sell |
4,696
-317
| -6% | -$1.36K | ﹤0.01% | 5086 |
|
|
2024
Q4 | $19.9K | Hold |
5,013
| – | – | ﹤0.01% | 5106 |
|
|
2024
Q3 | $19.9K | Hold |
5,013
| – | – | ﹤0.01% | 4934 |
|
|
2024
Q2 | $18.5K | Hold |
5,013
| – | – | ﹤0.01% | 5016 |
|
|
2024
Q1 | $21.3K | Sell |
5,013
-58
| -1% | -$202 | ﹤0.01% | 5020 |
|
|
2023
Q4 | $18.3K | Sell |
5,071
-3
| -0.1% | -$13 | ﹤0.01% | 5095 |
|
|
2023
Q3 | $29.1K | Hold |
5,074
| – | – | ﹤0.01% | 5090 |
|
|
2023
Q2 | $39.6K | Hold |
5,074
| – | – | ﹤0.01% | 5104 |
|
|
2023
Q1 | $59.7K | Hold |
5,074
| – | – | ﹤0.01% | 5086 |
|
|
2022
Q4 | $60.5K | Buy |
5,074
+318
| +7% | +$4.53K | ﹤0.01% | 5178 |
|
|
2022
Q3 | $106K | Hold |
4,756
| – | – | ﹤0.01% | 5161 |
|
|
2022
Q2 | $140K | Sell |
4,756
-250
| -5% | -$7.46K | ﹤0.01% | 5135 |
|
|
2022
Q1 | $166K | Buy |
5,006
+250
| +5% | +$8.89K | ﹤0.01% | 5152 |
|
|
2021
Q4 | $191K | Buy |
4,756
+1,012
| +27% | +$59.8K | ﹤0.01% | 5115 |
|
|
2021
Q3 | $304K | Buy |
3,744
+3,587
| +2,285% | +$321K | ﹤0.01% | 4879 |
|
|
2021
Q2 | $4K | Sell |
157
-34
| -18% | -$872 | ﹤0.01% | 5393 |
|
|
2021
Q1 | $5K | Hold |
191
| – | – | ﹤0.01% | 5147 |
|
|
2020
Q4 | $5K | Hold |
191
| – | – | ﹤0.01% | 4915 |
|
|
2020
Q3 | $3K | Hold |
191
| – | – | ﹤0.01% | 4915 |
|
|
2020
Q2 | $3K | Hold |
191
| – | – | ﹤0.01% | 4885 |
|
|
2020
Q1 | $2K | Hold |
191
| – | – | ﹤0.01% | 4871 |
|
|
2019
Q4 | $7K | Hold |
191
| – | – | ﹤0.01% | 4777 |
|
|
2019
Q3 | $5K | Hold |
191
| – | – | ﹤0.01% | 4789 |
|
|
2019
Q2 | $6K | Hold |
191
| – | – | ﹤0.01% | 4812 |
|
|
2019
Q1 | $17K | Hold |
191
| – | – | ﹤0.01% | 4623 |
|
|
2018
Q4 | $12K | Hold |
191
| – | – | ﹤0.01% | 4645 |
|
|
2018
Q3 | $20K | Hold |
191
| – | – | ﹤0.01% | 4659 |
|
|
2018
Q2 | $20K | Hold |
191
| – | – | ﹤0.01% | 4678 |
|
|
2018
Q1 | $21K | Hold |
191
| – | – | ﹤0.01% | 4564 |
|
|
2017
Q4 | $26K | Hold |
191
| – | – | ﹤0.01% | 4531 |
|
|
2017
Q3 | $31K | Hold |
191
| – | – | ﹤0.01% | 4531 |
|
|
2017
Q2 | $41K | Sell |
191
-12
| -6% | -$3.72K | ﹤0.01% | 4554 |
|
|
2017
Q1 | $81K | Buy |
+203
| New | +$87.6K | ﹤0.01% | 4374 |
|
BlackRock's NURO Position: Q2 2025 in Review
BlackRock sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q2 2025, closing a stake of 4,696 shares — an estimated $20.8K sold.
BlackRock first reported a position in NURO in Q1 2017 and held it in 33 quarters. The position peaked at $304K in Q3 2021. 0 funds tracked by Wall St. Rank hold NURO as of Q2 2025.
- BlackRock reported no remaining NeuroMetrix, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
- BlackRock sold 4,696 NeuroMetrix, Inc. Common Stock shares in Q2 2025, an estimated $20.8K.
- BlackRock first reported a position in NeuroMetrix, Inc. Common Stock in Q1 2017 and held it in 33 quarters.
- BlackRock's NeuroMetrix, Inc. Common Stock position peaked at $304K in Q3 2021.
- 0 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q2 2025.
Based on BlackRock's 13F filing for Q2 2025, filed 12 Aug 2025.